Advertisement

Topics

Takeda Announces Further Details of Splitting off (Simple Absorption-type Split) of Japan Consumer Healthcare Business Unit

09:54 EST 21 Feb 2017 | Takeda

Osaka, Japan, February 20, 2017 – Takeda Pharmaceutical Company Limited (TSE:4502) ("Takeda") today announced that it has entered into an agreement with Takeda Consumer Healthcare Company Limited (TCHC), a wholly-owned subsidiary of Takeda, to transfer its Japan Consumer Healthcare Business Un

Original Article: Takeda Announces Further Details of Splitting off (Simple Absorption-type Split) of Japan Consumer Healthcare Business Unit

NEXT ARTICLE

More From BioPortfolio on "Takeda Announces Further Details of Splitting off (Simple Absorption-type Split) of Japan Consumer Healthcare Business Unit"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...